FDA Import Refusal 799-9303351-2/11/1 — Glaxosmithkline
The FDA refused shipment 799-9303351-2/11/1 from Glaxosmithkline (United Kingdom) on Jun 29, 2022. The refused product falls under Drugs and Biologics — ALBENDAZOLE (ANTIPARASITIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 29, 2022
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 60ZDL02 ALBENDAZOLE (ANTIPARASITIC)
- Charges
- 118,75